1. A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Issue 12 (4th October 2020) Authors: Austin, Cary D.; Gonzalez Edick, Melissa; Ferrando, Ronald E.; Solon, Margaret; Baca, Miriam; Mesh, Kathryn; Bradding, Peter; Gauvreau, Gail M.; Sumino, Kaharu; FitzGerald, J. Mark; Israel, Elliot; Bjermer, Lief; Bourdin, Arnaud; Arron, Joseph R.; Choy, David F.; Olsson, Julie K.; Abreu, Francis;... Journal: Clinical & experimental allergy Issue: Volume 50:Issue 12(2020) Page Start: 1342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler. Issue 2 (26th May 2016) Authors: Price, David B.; Colice, Gene; Israel, Elliot; Roche, Nicolas; Postma, Dirkje S.; Guilbert, Theresa W.; van Aalderen, Willem M.C.; Grigg, Jonathan; Hillyer, Elizabeth V.; Thomas, Victoria; Martin, Richard J. Journal: ERJ open research Issue: Volume 2:Issue 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma. Issue 3 (May 2023) Authors: Salciccioli, Justin D.; Israel, Elliot Journal: Current opinion in pulmonary medicine Issue: Volume 29:Issue 3(2023) Page Start: 209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist. Issue 1 (June 2016) Authors: Roche, Nicolas; Colice, Gene; Israel, Elliot; Martin, Richard; Dorinsky, Paul; Postma, Dirkje; Guilbert, Theresa; Grigg, Jonathan; Aalderen, Willem; Barion, Francesca; Hillyer, Elizabeth; Thomas, Victoria; Burden, Anne; Brett McQueen, R.; Price, David Journal: Pulmonary therapy Issue: Volume 2:Issue 1(2016) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing. (December 2018) Authors: Kesten, Steven; Israel, Elliot; Li, Guangxi; Mitchell, Jolyon; Wise, Robert; Stern, Tom Journal: Pulmonary pharmacology & therapeutics Issue: Volume 53(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis‐associated variants in the Severe Asthma Research Program. Issue 7 (5th May 2022) Authors: Izquierdo, Manuel E.; Marion, Chad R.; Moore, Wendy C.; Raraigh, Karen S.; Taylor‐Cousar, Jennifer L.; Cutting, Gary R.; Ampleford, E.; Hawkins, Gregory A.; Zein, Joe; Castro, M.; Denlinger, Loren C.; Erzurum, Serpil C.; Fahy, John V.; Israel, Elliot; Jarjour, Nizar N.; Mauger, David; Levy, Bruce... Journal: Pediatric pulmonology Issue: Volume 57:Issue 7(2022) Page Start: 1782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. Issue 1 (December 2016) Authors: van der Molen, Thys; Postma, Dirkje; Martin, Richard; Herings, Ron; Overbeek, Jetty; Thomas, Victoria; Miglio, Cristiana; Dekhuijzen, Richard; Roche, Nicolas; Guilbert, Theresa; Israel, Elliot; van Aalderen, Wim; Hillyer, Elizabeth; van Rysewyk, Simon; Price, David Journal: BMC pulmonary medicine Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma. Issue 8 (23rd March 2020) Authors: Howarth, Peter; Quirce, Santiago; Papi, Alberto; Israel, Elliot; Mallett, Stephen; Bates, Stewart; Yancey, Steve; Albers*, Frank C.; Kwon, Namhee Journal: Allergy Issue: Volume 75:Issue 8(2020) Page Start: 2085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. Issue 1 (December 2016) Authors: van der Molen, Thys; Postma, Dirkje; Martin, Richard; Herings, Ron; Overbeek, Jetty; Thomas, Victoria; Miglio, Cristiana; Dekhuijzen, Richard; Roche, Nicolas; Guilbert, Theresa; Israel, Elliot; van Aalderen, Wim; Hillyer, Elizabeth; van Rysewyk, Simon; Price, David Journal: BMC pulmonary medicine Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Flexibility and strength training in asthma: A pilot study. (2nd December 2018) Authors: Olenich, Sara; Waterworth, Graeme; Badger, Gary J.; Levy, Bruce; Israel, Elliot; Langevin, Helene M. Journal: Journal of asthma Issue: Volume 55:Number 12(2018) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗